Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and diabetes mellitus: An unholy interaction of two pandemics
Rimesh Pal, Sanjay Kumar Bhadada
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 4, pp. 513-517
Open Access | Times Cited: 282

Showing 1-25 of 282 citing articles:

COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation
Ioannis Zabetakis, Ronan Lordan, Catherine Norton, et al.
Nutrients (2020) Vol. 12, Iss. 5, pp. 1466-1466
Open Access | Times Cited: 506
Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study
Kathryn E. Mansfield, Rohini Mathur, John Tazare, et al.
The Lancet Digital Health (2021) Vol. 3, Iss. 4, pp. e217-e230
Open Access | Times Cited: 309
Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021
Lyudmyla Kompaniyets, Audrey F. Pennington, Alyson B. Goodman, et al.
Preventing Chronic Disease (2021) Vol. 18
Open Access | Times Cited: 297
COVID‐19‐associated mucormycosis: An updated systematic review of literature
Rimesh Pal, Birgurman Singh, Sanjay Kumar Bhadada, et al.
Mycoses (2021) Vol. 64, Iss. 12, pp. 1452-1459
Open Access | Times Cited: 249
COVID-19 and diabetes: The why, the what and the how
Sarah Cuschieri, Stephan Grech
Journal of Diabetes and its Complications (2020) Vol. 34, Iss. 9, pp. 107637-107637
Open Access | Times Cited: 149
COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges
Rimesh Pal, Sanjay Kumar Bhadada, Anoop Misra
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 2, pp. 505-508
Open Access | Times Cited: 127
Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia
Jesús Chávez‐Reyes, Carlos Enrique Escárcega‐González, Erika Chavira-Suárez, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 112
ACE2: the molecular doorway to SARS-CoV-2
Miriam Marlene Medina-Enríquez, Sandra López‐León, José Alberto Carlos-Escalante, et al.
Cell & Bioscience (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 119
Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literature
Rimesh Pal, Mainak Banerjee, Urmila Yadav, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 6, pp. 1563-1569
Open Access | Times Cited: 110
The Syndemics and Structural Violence of the COVID Pandemic: Anthropological Insights on a Crisis
Merrill Singer, Barbara Rylko‐Bauer
Open Anthropological Research (2020) Vol. 1, Iss. 1, pp. 7-32
Open Access | Times Cited: 110
Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals
Ronald Andrew Seaton, Cheryl Gibbons, Lesley Cooper, et al.
Journal of Infection (2020) Vol. 81, Iss. 6, pp. 952-960
Open Access | Times Cited: 102
Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage
Sandra Amor, Laura Fernández Blanco, David Baker
Clinical & Experimental Immunology (2020) Vol. 202, Iss. 2, pp. 193-209
Open Access | Times Cited: 95
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
Simone Cristina Soares Brandão, Júlia de Oliveira Xavier Ramos, Luca Terracini Dompieri, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 58, pp. 102-110
Open Access | Times Cited: 89
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota
Dan Cristian Vodnar, Laura Mitrea, Bernadette-Emőke Teleky, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 82
Challenges of routine diabetes care during COVID-19 era: A systematic search and narrative review
Mohammad Mohseni, Shiler Ahmadi, Saber Azami‐Aghdash, et al.
Primary care diabetes (2021) Vol. 15, Iss. 6, pp. 918-922
Open Access | Times Cited: 68
Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection
López Castañeda, Nallely García‐Larragoiti, Alan Cano‐Méndez, et al.
Clinical and Applied Thrombosis/Hemostasis (2021) Vol. 27
Open Access | Times Cited: 57
Consequences of COVID-19 for the Pancreas
Urszula Abramczyk, Maciej Nowaczyński, Adam Słomczyński, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 864-864
Open Access | Times Cited: 53
Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States
Fan Lv, Xu Gao, Amy Huang, et al.
EClinicalMedicine (2022) Vol. 54, pp. 101671-101671
Open Access | Times Cited: 39
Prevalence of pharmaceuticals and personal care products, microplastics and co-infecting microbes in the post-COVID-19 era and its implications on antimicrobial resistance and potential endocrine disruptive effects
Manish Kumar, Payal Mazumder, Rahul Silori, et al.
The Science of The Total Environment (2023) Vol. 904, pp. 166419-166419
Closed Access | Times Cited: 27
COVID-19: Diabetes Perspective—Pathophysiology and Management
Siva Dallavalasa, SubbaRao V. Tulimilli, Prakash Janhavi, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 184-184
Open Access | Times Cited: 24
Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review
Subham Das, A Ramachandran, Sumit Birangal, et al.
Life Sciences (2020) Vol. 258, pp. 118202-118202
Open Access | Times Cited: 68
Coronavirus disease 2019 and the pancreas
Jayanta Samanta, Rohit Gupta, Mini P. Singh, et al.
Pancreatology (2020) Vol. 20, Iss. 8, pp. 1567-1575
Open Access | Times Cited: 61
Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment
Vicki Osborne, Miranda Davies, Samantha Lane, et al.
Drug Safety (2020) Vol. 43, Iss. 8, pp. 809-821
Open Access | Times Cited: 60
Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review
Vijay Viswanathan, Anudeep Puvvula, Ankush D. Jamthikar, et al.
World Journal of Diabetes (2021) Vol. 12, Iss. 3, pp. 215-237
Open Access | Times Cited: 48
Implications of SARS-Cov-2 infection on eNOS and iNOS activity: Consequences for the respiratory and vascular systems
Lara Mendes Ferreira Guimarães, Caio Vinícius Teles Rossini, Claudiana Lameu
Nitric Oxide (2021) Vol. 111-112, pp. 64-71
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top